Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Return on Equity [ROE] (2012 - 2026)

Updated

Grace Therapeutics' Return on Equity [ROE] came in at -41.30% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 28.93 percentage points from -12.37% a year earlier and down 5.23 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Return on Equity [ROE] (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics' Return on Equity [ROE] was -11.94%, up 2.97 percentage points from FY2025.

  • Return on Equity [ROE] has increased in each of the last three fiscal years, with a five-year change of +45.38 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Equity [ROE] was -14.91% in FY2025 (+4.91 pp), -19.82% in FY2024 (+28.33 pp), -48.15% in FY2023 (-36.17 pp) and -11.98% in FY2022 (+45.35 pp).
  • The fiscal Q2 2027 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q3 2024.
  • Year-over-year, Return on Equity [ROE] increased in six of the last eight quarters, with an average year-over-year change of +2.44 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q1 2025 (a gain of 44.64 percentage points), and the weakest in fiscal Q1 2024 (a drop of 52.99 percentage points).
  • Business Quant data shows GRCE's Return on Equity [ROE] at -36.07% (Q1 2027), -12.10% (Q4 2026) and -9.36% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 19.33%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.63%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 21.60%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -31.17%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.66%
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -41.30%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -41.30%
Jun 30, 2026 -36.07%
Mar 31, 2026 -12.10%
Dec 31, 2025 -9.36%
Sep 30, 2025 -12.37%
Jun 30, 2025 -15.85%
Mar 31, 2025 -16.11%
Dec 31, 2024 -24.70%
Sep 30, 2024 -20.10%
Jun 30, 2024 -18.90%
Mar 31, 2024 -20.33%
Dec 31, 2023 -59.01%
Sep 30, 2023 -61.60%
Jun 30, 2023 -63.54%
Mar 31, 2023 -51.53%
Dec 31, 2022 -17.52%
Sep 30, 2022 -16.75%
Jun 30, 2022 -10.56%
Mar 31, 2022 -8.95%
Dec 31, 2021 -10.26%
API Access

Grace Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY